TTK Healthcare Ltd

  • BSE Code : 507747
  • NSE Symbol : TTKHLTCARE
  • ISIN : INE910C01018
  • Industry :DIVERSIFIED - MEDIUM / SMALL

up-arrow 789.10 5.60(0.71%)

Open Price ()

766.50

Prev. Close ()

783.50

Volume (No’s)

2,014

Market Cap ()

1,115.02

Low Price ()

756.05

High Price ()

793.50

 

Board Meetings

Start Date End Date Purpose
02-Jan-2026 22-Jan-2026 TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2026 inter alia to consider and approve Prior Board Meeting Intimation Outcome of the Board Meeting 22.01.2026 (As per BSE Announcement dated on: 22.01.2026)
22-Dec-2025 22-Dec-2025 Board Meeting Outcome held on December 22, 2025
25-Sep-2025 17-Oct-2025 TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 inter alia to consider and approve Meeting of the Board of Directors to be held on October 17 2025 to consider and approve the Unaudited Financial Results of the Company for the Second Quarter ending September 30 2025 Outcome of the Board Meeting held on October 17, 2025 (As per BSE Announcement dated on: 17.10.2025)
09-Jul-2025 04-Aug-2025 Quarterly Results TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2025 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company scheduled to be held on Monday, August 04, 2025. (As Per BSE Announcement dated on 09.07.2025) Outcome of the Board meeting held on August 04, 2025 (As Per BSE Announcement Dated on: 04.08.2025)
12-May-2025 23-May-2025 TTK Healthcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday the May 23 2025 inter alia (i) to consider and approve the fourth quarter and Audited Financial Results of the Company for the year ended March 31 2025; and (ii) to consider and recommend dividend if any for the financial year 2024-25. Dividend Recommendation by the Board Dividend of Rs.10/- per Equity Share of Rs.10/- each (100%), for the financial year ended March 31, 2025 which shall be paid within 30 days from the date of AGM, subject to the approval of the Shareholders. (As Per BSE Announcement Dated on 23.05.2025)

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew